Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises OptiGroup in connection with the acquisition of PacksOn in Sweden
Mandate

Vinge advises OptiGroup in connection with the acquisition of PacksOn in Sweden

March 30, 2021 Employment and Benefits Real Estate and Construction Intellectual Property M&A EU, Competition and Regulatory Corporate Crime & Compliance Insurance Law Environmental Law IT, Telecommunications and Outsourcing Banking and Finance Commercial Agreements

OptiGroup has entered into an agreement to acquire 100% of the shares in PacsOn Sverige AB from Herenco AB. The transaction is subject to the approval of the Swedish Competition Authority.

PacsOn, with a turnover of 840 million SEK in 2020, is a leading provider of products and supply solutions within packaging and business consumables. PacsOn will become part of OptiGroup's Business Area Packaging and will continue to operate under its current brand.

Vinge’s team consisted of partner Christina Kokko together with Johanna Wiberg, Elsie Nassar and Ellen Åkerdahl Flygt (M&A), Nina Gransäter (Banking and Finance), Christoffer Nordin and Alva Hägglund (Commercial Agreements), Ebba Svenburg (Employment), Mathilda Persson (IT), Agnes Perbo (GDPR) Sofia Bergenstråhle (Intellectual Property), Kristoffer Larson (Real Property), Lina Österberg (Environmental law), Victoria Gunnerek (Competition law), Tove Lövgren Frisk (Compliance) and Ellinor Gyllenhammar (VDR).

 

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025